ST

Srinivas Tadepally

Active Director Cfo DIN 06579879
DIN 06579879 First appointment Mar 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Mar 2013
Shareholding value •••• Premium profile

About Srinivas Tadepally

Data last updated:

Srinivas Tadepally is a Cfo at Bharat Biotech International Limited (since 2015), Cfo at Chiron Behring Vaccines Private Limited (since 2020) and Designated Partner at Skebio Infra Llp (since 2021). The companies operate in Pharma and Infrastructure and Utilities. The 3 current companies with reported revenue have a combined latest revenue of ₹1,794 Cr; the largest is Bharat Biotech International Limited at ₹1,700 Cr (FY 2025). Earlier, Srinivas Tadepally was a Director at Biovet Private Limited (2013–2019).

DIN 06579879
Primary Designation Cfo
Industry Pharma
First Appointment 25 Mar 2013
Oldest Company Age 30 yrs
Largest company Bharat Biotech International Limited · ₹1,700 Cr (FY 2025)
Combined revenue ₹1,794 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bharat Biotech International Limited U24230TG1996PLC023232
Cfo06 Jan 20151996₹1,700 Cr (FY 2025)Active
Cfo25 Jan 20201997₹94.53 Cr (FY 2025)Active
Skebio Infra Llp AAZ-8975
Designated Partner15 Dec 20212021₹5.3 Lakh (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biovet Private Limited U24235KA2005PTC035491
Director25 Mar 20132005₹249 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Skebio Infra Llp
Bharat Biotech International Limited
Chiron Behring Vaccines Private Limited
Biovet Private Limited
Premium access

Shareholding and investment profile for Srinivas Tadepally

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivas Tadepally

Srinivas Tadepally currently holds 3 directorships: Bharat Biotech International Limited (Cfo, since 06 Jan 2015, revenue ₹1,700 Cr (FY 2025)); Chiron Behring Vaccines Private Limited (Cfo, since 25 Jan 2020, revenue ₹94.53 Cr (FY 2025)); Skebio Infra Llp (Designated Partner, since 15 Dec 2021, revenue ₹5.3 Lakh (FY 2023)).

Srinivas Tadepally was first appointed on 25 Mar 2013 as Director at Biovet Private Limited. The most recent appointment on record is 15 Dec 2021 at Skebio Infra Llp.

The 3 current companies of Srinivas Tadepally that report revenue have a combined latest revenue of ₹1,794 Cr: Bharat Biotech International Limited ₹1,700 Cr (FY 2025); Chiron Behring Vaccines Private Limited ₹94.53 Cr (FY 2025); Skebio Infra Llp ₹5.3 Lakh (FY 2023).

Srinivas Tadepally held 1 earlier board appointment: Biovet Private Limited (Director, 25 Mar 2013 to 07 Sep 2019).

The current boards of Srinivas Tadepally's companies include Kannan Soundararajan (Bharat Biotech International Limited), Krishna Mohan Vadrevu (Bharat Biotech International Limited), Krishna Murthy Ella (Bharat Biotech International Limited), Prathivadibhayankaram Ranganathac Rajagopalan (Bharat Biotech International Limited), Sai Prasad Devarajulu (Bharat Biotech International Limited), Suchitra Ella (Bharat Biotech International Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available